Julie Johnson - Concepedia

Author

Julie Johnson

St George's, University of London ORCID

Also Known As

JULIE D. JOHNSON, Julie D Johnson, Julie D. Johnson, Julie Johnson

Publications

800

Citations

H-Index

Concepts

All Affiliations

St George's, University of London St George's Hospital University of Reading St George's Hospital Inserm

About

Julie Johnson is an author at St George's, University of London specializing in medicine, pathology, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	472
2	Public Health	2	2	88
3	Epidemiology	2	2	88
4	Engineering	1	1	14
5	Biostatistics	1	1	96

Julie Johnson

Publications

786

Citations

H-Index

Page 1

	Year	Citations
Characterization of <i>Salmonella enterica</i> Derivatives Harboring Defined <i>aroC</i> and <i>Salmonella</i> Pathogenicity Island 2 Type III Secretion System ( <i>ssaV</i> ) Mutations by Immunization of Healthy Volunteers Zoë Hindle, Steven N. Chatfield, Jo Phillimore, Infection and Immunity	2002	202
Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis Amanda Brennan, Khin M. Gyi, David M. Wood, Journal of Cystic Fibrosis Respiratory InfectionAirway Glucose ConcentrationsInfectious Respiratory DiseasePulmonary FibrosisRespiratory Pathogens	2006	198
A second European collaborative study on polymerase chain reaction for<i>Toxoplasma gondii</i>, involving 15 teams Hervé Pelloux, Edward Guy, Maria Cristina Angelici, FEMS Microbiology Letters Polymerase Chain ReactionParasitic DiseaseParasitic ProtozoaMedicinePathogenesis	1998	96
Diagnosis of Cerebral Toxoplasmosis in Association with AIDS Using the Polymerase Chain Reaction Richard Holliman, Julie Johnson, D. Savva Scandinavian Journal of Infectious Diseases	1990	58
Breast cancer patients' personality style, age, and treatment decision making Julie Johnson, Cleora S. Roberts, Charles E. Cox, Journal of Surgical Oncology	1996	54
Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus Alimuddin Zumla, D. Savva, Ruth B. Wheeler, Transactions of the Royal Society of Tropical Medicine and Hygiene Primary ImmunodeficiencyParasitic DiseaseEpidemiologyDye TestMedicine	1991	50
Safety and immunogenicity of SC599, an oral live attenuated Shigella dysenteriae type-1 vaccine in healthy volunteers: Results of a Phase 2, randomized, double-blind placebo-controlled trial Odile Launay, Christine Sadorge, Nathalie Jolly, Vaccine VaccinationVaccine SafetyVaccine DevelopmentHealthy VolunteersImmunology	2009	44
Epidemiology of invasive pneumococcal disease in Kumasi, Ghana Richard Holliman, Helen Liddy, Julie Johnson, Transactions of the Royal Society of Tropical Medicine and Hygiene Klebsiella PneumoniaeBacterial PathogensDrug ResistanceInvasive Pneumococcal DiseaseSystemic Sepsis	2006	38
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 ΔicsA Δent Δfep ΔstxA:HgR oral vaccine SC599 in healthy human adult volunteers Christine Sadorge, Anna Julienne Selbé Ndiaye, Nathalie Beveridge, Vaccine VaccinationVaccine DevelopmentImmunologyPhase 1Infection Control	2007	20
Detection of <i>Toxoplasma gondii</i> using the polymerase chain reaction Julie Johnson, Richard Holliman, D. Savva Biochemical Society Transactions EngineeringLaboratory ImmunologyImmunologyPathologyImmune System	1990	14

Page 1